Wide Ranks

IDXX

IDEXX Laboratories, Inc.

421.76

Top Statistics
Market Cap 34 B Forward PE 35.49 Revenue Growth 6.60 %
Current Ratio 1.42 Trailing PE 40.63 Earnings Growth 10.70 %
Profit Margins 22.53 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 27.11 Enterprise / Revenue 9.16 Price To Sales Trailing12 Months 8.98
Profitability
Profit Margins 22.53 % Operating Margins 37.45 %
Balance Sheet
Total Cash 308 M Total Cash Per Share 3.77 Total Debt 998 M
Total Debt To Equity 61.70 Current Ratio 1.42 Book Value Per Share 19.72
All Measures
Short Ratio 206.00 % Message Board Id finmb_29729 Fax 207 556 4346
Shares Short Prior Month 2 M Return On Equity 0.5942 City Westbrook
Uuid f576b05b-2a7f-3f70-9980-7b0489373c04 Previous Close 417.32 First Trade Date Epoch Utc 677 M
Book Value 19.72 Beta 1.36 Total Debt 998 M
Volume 472190 Price To Book 21.38 Last Split Date 1 B
Fifty Two Week Low 398.50 Total Cash Per Share 3.77 Total Revenue 3 B
Shares Short Previous Month Date 1 B Target Median Price 472.50 Max Age 86400
Recommendation Mean 2.54 Sand P52 Week Change 0.3133 Operating Margins 37.45 %
Target Mean Price 476.76 Net Income To Common 866 M Short Percent Of Float 0.0255
Implied Shares Outstanding 81 M Trailing Peg Ratio 443.94 % Last Fiscal Year End 1 B
Average Daily Volume10 Day 633630 Average Volume10days 633630 Total Cash 308 M
Next Fiscal Year End 1 B Revenue Per Share 46.45 Held Percent Insiders 0.0094
Ebitda Margins 33.80 % Trailing PE 40.63 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 417.32 Target Low Price 400.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 455.50 Open 419.91
Free Cashflow 792 M State ME Dividend Yield 0.00 %
Return On Assets 0.2279 Time Zone Short Name EST Trailing Eps 10.38
Day Low 417.48 Address1 One IDEXX Drive Shares Outstanding 81 M
Price Hint 2 Target High Price 566.00 Website https://www.idexx.com
52 Week Change -0.0946 Average Volume 567417 Earnings Quarterly Growth 9.70 %
Forward Eps 11.96 Recommendation Key hold Compensation As Of Epoch Date 1 B
Quick Ratio 88.80 % Last Split Factor 2:1 Regular Market Day High 423.36
Is_sp_500 True Profit Margins 22.53 % Debt To Equity 61.70
Fifty Two Week High 583.39 Day High 423.36 Shares Short 1 M
Regular Market Open 419.91 Industry Key diagnostics-research Earnings Growth 10.70 %
Enterprise To Revenue 9.16 Revenue Growth 6.60 % Shares Percent Shares Out 0.0198
Operating Cashflow 916 M Currency USD Time Zone Full Name America/New_York
Market Cap 34 B Is_nasdaq_100 True Zip 04092
Quote Type EQUITY Industry Diagnostics & Research Long Name IDEXX Laboratories, Inc.
Regular Market Day Low 417.48 Held Percent Institutions 0.9423 Current Price 421.76
Enterprise To Ebitda 27.11 Financial Currency USD Current Ratio 1.42
Gross Margins 60.72 % Industry Disp Diagnostics & Research Number Of Analyst Opinions 12
Country United States Float Shares 80 M Two Hundred Day Average 492.74
Enterprise Value 35 B Price To Sales Trailing12 Months 8.98 Forward PE 35.49
Regular Market Volume 472190 Ebitda 1 B Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally.

The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.

It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community.

In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits.

Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E.

coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups.

Additionally, the company offers human medical point-of-care products and laboratory diagnostics services.

The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.

IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.